Expert commission in Luxembourg

How it works

The Division of Pharmacy and Medicines (Division de la pharmacie et des médicaments - DPM) prepares the Marketing Authorisation Application (MAA) dossiers and submits them to the expert commission, which is responsible for issuing a Marketing Authorisation (MA) opinion. The commission meets once a month, examines the dossiers from a scientific point of view, and issues a final MA opinion, including the conditions under which the medicinal product should be prescribed and any potential delivery restrictions. The final opinion of the expert commission is then forwarded to the Ministry of Health, which issues the final decision.

Members

The expert commission is composed of the following members:

• four delegates from the ministry responsible for health matters, including two physicians and two pharmacists;
• two members representing the medical profession;
• two members representing the pharmaceutical profession, including a representative from the hospital sector, and from the non-hospital sector;
• two representatives from the Social Security Medical Board (Contrôle médical de la sécurité sociale);
• a representative from the Union of Health Insurance Funds (Union des caisses de maladie);
• two members from the Committee on Medicinal Products (Comité des spécialités pharmaceutiques).

An alternate is appointed for each member.

Members are appointed by the minister responsible for health matters. That minister also appoints the Chair and Secretary, who may be a person who is not on the Committee.

The commission is currently composed of the following members (members + alternates):